Independent Retail Shareholders of ITRM
Independent Retail Shareholders of ITRM
A group of retail shareholders working responsibly to stay informed, understand our rights, and improve governance at Iterum Therapeutics.
Join the shareholder list
Get updates on shareholder information, governance topics, and important dates related to Iterum Therapeutics.
Informational only. Joining does not obligate you to vote or take any action. Participation is completely voluntary.
We will never sell your information
Why we're organizing
Retail shareholders collectively own a significant portion of ITRM. By organizing, we can make an impact and difference.
Stay Informed
Share important updates on governance issues, voting timelines, and key updates.
Coordinate Responsibility
Understand thresholds, timing and options as retail investors, without outside direction.
Focus on Long Term
Work toward improved transparency, accountability, long-term value and ultimately shareholders’ best interest for commercialization and sale of the company.
VOTE NO ON ALL PROXY ITEMS
Iterum believes it is appropriate at this point to ask for additional shares and vote for a reverse split. This is absolutely the exact opposite what a responsible CEO should do. Our goal is and always will be in the best interest of representing the majority retail shareholders. What we need is simple; non-dilutive funding.
We have an FDA approved drug, with strong partnerships, Medicare Part D milestones, and approvals from PBM and more in the pipeline. A CEO with intentions to uphold fiduciary rights with these accomplishments would secure funding that’s in the best interest of the shareholders whom successfully assisted his company through the FDA approval process.
It is therefore our recommendations that all retail votes no in this upcoming proxy and force a buyout or alternative financing solution.
Congratulations on a successful Proxy in favor of Retail
This was not easy. It required coordination, conviction, and the willingness to stand up when it would have been simpler to stay silent. But we’re not giving up.
This vote proves something important: retail shareholders matter. When organized and informed, our voices carry weight. This was never just about one proposal — it was about accountability, transparency, and long-term value.
Today is a milestone. Not the finish line.
We remain committed to protecting shareholder interests, demanding clarity, and staying engaged. Progress doesn’t happen overnight, and setbacks don’t define us. Persistence does.
We will continue to monitor developments, share plain-English updates, and explore every appropriate avenue to ensure retail shareholders are represented.
This is only the beginning. We’re not going anywhere.
Why we ask for this information
To understand whether retail shareholders have sufficient participation to meaningfully engage, we need high-level, self-reported data. This information is used only for aggregate analysis and communication.
✔ YOUR NAME – For high-level identification
✔ EMAIL ADDRESS – Primary communication channel
✔ APPROXIMATE SHARE COUNT – To understand potential participation%
What Happens After You Join
- You-receive confirmation and future updates via email
- We share-plain-English explanations of shareholder rights
- If meaningful participation exists, options will be communicated via email on how we move onto the next step.
Join the shareholder list
Get updates on shareholder information, governance topics, and important dates related to Iterum Therapeutics.
Informational only. Joining does not obligate you to vote or take any action. Participation is completely voluntary.
We will never sell your information